Skip to main content

LGC to Market Gentris' GentriSure Controls in Europe, Asia

NEW YORK (GenomeWeb News) — Gentris today said that London-based reference materials company LGC Promochem will market its GentriSure products to labs in Europe and India.
 
Gentris, a genotyping products and services company based in Morrisville, NC, said the human genomic reference controls now contain polymorphisms for the CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes. The firm added that they are derived from human donors and do not include artificial DNA sequences.   
 
Financial terms of the deal were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.